Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Montana

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Expert Opinion on Investigational Drugs|July 5, 2005
The therapeutic potential of PDE4 inhibitorsH J Dyke, J G Montana
Journal of Molecular Graphics & Modelling|July 14, 2001
Theoretical hydrogen bonding parameters for drug designE Gancia, J G Montana, D T Manallack
Bioorganic & Medicinal Chemistry|January 30, 1999
The design, synthesis, and evaluation of novel conformationally rigid analogues of sialyl Lewis(x)P V Murphy, R E Hubbard, D T Manallack, et al.
Combinatorial Chemistry & High Throughput Screening|March 7, 2000
Solid-phase synthesis and biological screening of N-alpha-mercaptoamide template-based matrix metalloprotease inhibitorsJ F Lynas, S L Martin, B Walker, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
PDE4 inhibitors: new xanthine analoguesJ G Montana, N Cooper, H J Dyke, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2001
Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitorsA D Baxter, R Bhogal, J Bird, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Synthesis and evaluation of a novel series of phosphodiesterase IV inhibitors. A potential treatment for asthmaS C Beasley, N Cooper, L Gowers, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2001
Synthesis and structure-activity relationships of guanine analogues as phosphodiesterase 7 (PDE7) inhibitorsM J Barnes, N Cooper, R J Davenport, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Aryl sulfonamides as selective PDE4 inhibitorsJ G Montana, G M Buckley, N Cooper, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
5,5-trans lactone-containing inhibitors of serine proteases: identification of a novel, acylating thrombin inhibitorH Finch, N A Pegg, J McLaren, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|July 5, 2005
The therapeutic potential of PDE4 inhibitorsH J Dyke, J G Montana
Journal of Molecular Graphics & Modelling|July 14, 2001
Theoretical hydrogen bonding parameters for drug designE Gancia, J G Montana, D T Manallack
Bioorganic & Medicinal Chemistry|January 30, 1999
The design, synthesis, and evaluation of novel conformationally rigid analogues of sialyl Lewis(x)P V Murphy, R E Hubbard, D T Manallack, et al.
Combinatorial Chemistry & High Throughput Screening|March 7, 2000
Solid-phase synthesis and biological screening of N-alpha-mercaptoamide template-based matrix metalloprotease inhibitorsJ F Lynas, S L Martin, B Walker, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
PDE4 inhibitors: new xanthine analoguesJ G Montana, N Cooper, H J Dyke, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2001
Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitorsA D Baxter, R Bhogal, J Bird, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Synthesis and evaluation of a novel series of phosphodiesterase IV inhibitors. A potential treatment for asthmaS C Beasley, N Cooper, L Gowers, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2001
Synthesis and structure-activity relationships of guanine analogues as phosphodiesterase 7 (PDE7) inhibitorsM J Barnes, N Cooper, R J Davenport, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Aryl sulfonamides as selective PDE4 inhibitorsJ G Montana, G M Buckley, N Cooper, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
5,5-trans lactone-containing inhibitors of serine proteases: identification of a novel, acylating thrombin inhibitorH Finch, N A Pegg, J McLaren, et al.
Pageof 2